Aurinia Pharmaceuticals AUPH Return on invested capital

Return on invested capital at other companies

Rogers CorporationROG

-4.6%-9.0pp

Vera TherapeuticsVERA

-77.1%+219pp

ANI PharmaceuticalsANIP

21.3%+21.3pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

Theravance BiopharmaTBPH

1.5%+0.8pp

Opko HealthOPK

-3.7%-1.6pp

FAQ

What is Aurinia Pharmaceuticals's return on invested capital?

Aurinia Pharmaceuticals (AUPH) reported return on invested capital of 33.7% in Q2 2026.

How has Aurinia Pharmaceuticals's return on invested capital changed year-over-year?

Aurinia Pharmaceuticals's return on invested capital increased by 162.5% year-over-year, from 12.8% to 33.7%.

What is the long-term trend for Aurinia Pharmaceuticals's return on invested capital?

Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's return on invested capital has grown at a -30.2% compound annual growth rate (CAGR), from -90.4% to 21.4%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.